Comparison of peripheral blood and monocyte-derived DC Interestingly, both types of DC were equivalent with respect to stimulation of allogeneic-T cell proliferation and presentation of peptides to CTL lines. These distinct differences are of particular importance when considering the choice of DC types for clinical applications.
Introduction
Dendritic cells (DC) are rare bone marrow-derived cells, involved in antigen capture, processing and presentation. DC are uniquely able to prime a naïve T cell response. 1 Generation of CD34 + -derived DC requires 10-28 days in vitro culture, 5, 6 whilst DC generated in vitro from CD14 + monocytes (MoDC) require 5-7 days. 7, 8 Although their physiological relevance in vivo remains unclear, MoDC are the major DC type used in vaccine-based clinical studies. 3, 4 MoDC have also been used to establish many of the biologic paradigms of DC function. 1, 2 An alternative, and perhaps more physiological, source of DC in humans are the immature DC populations found in peripheral blood. 9, 10 At least two PBDC populations, constituting less than 1% of total mononuclear cells, exist in human peripheral blood:
CD1b/c + PBDC and IL-3R + plasmacytoid DC (PDC). [9] [10] [11] [12] [13] Several cytokines are known to expand the number of these PBDC types in vivo, including G-CSF and Flt-3 ligand (FL). 9, 14, 15 FL expands both human CD1b/c + PBDC and IL-3R + PDC 9, 10, [14] [15] [16] [17] [18] and has anti-tumor effects in animal models. [19] [20] [21] It has been suggested that the CD1b/c + PBDC subset in peripheral blood is related to the CD14-derived dermal DC and to germinal center DC. 6, 22, 23 Both of these types of DC appear to be of myeloid origin and can differentiate into Langerhans cells in the presence of TGF-. 12, 24 However, little is currently known of the functional differences between the CD1b/c + PBDC and MoDC types (e.g. antigen uptake capacity, migration, cytokine secretion and regulation of T cell function).
Few direct comparisons between DC types have been reported. Comparisons of CD34 + -derived DC and MoDC suggest that CD34 + -derived DC may be superior at activating low frequency, peptide-specific cytotoxic T lymphocytes. [25] [26] [27] [28] Others have reported that IL-3R 5 allogeneic donor sources. Thus, the degree to which donor-to-donor variation contributes to the observed functional differences may be significant.
We performed a clinical trial that evaluated FL (to expand PBDC numbers) with or without peptide vaccination in patients with malignant melanoma. 37 The present study describes the functional analysis of FL-expanded CD1b/c + PBDC isolated from these patients and compares them with autologous MoDC. Furthermore, CD1b/c + PBDC and autologous MoDC from healthy donors were also compared to exclude the possibility that functional differences between DC types from cancer patients were due to the cancer itself or alterations in DC behavior due to FL administration. We found major differences between the responses of MoDC and CD1b/c + PBDC towards three different classes of physiologic stimuli with respect to migratory function, cytokine production and regulation of T cell function.
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Materials and Methods

Media
Monoclonal antibodies and cytokines
Flow cytometric analysis of DC and T cells was performed using the following monoclonal antibodies: FITC-conjugated IgG1 isotype control; PE-conjugated IgG1 isotype control; antiCD1a, anti-CD1c; anti-CD1d; anti-CD45RA; anti-CD80; anti-CD83; anti-CD86; anti-CD123 (IL-3R ); anti-HLA-DR; anti-macrophage mannose receptor (MMR); anti-CXCR3, anti-CD3, anti -CD8, anti-IFN-(all from PharMingen/Becton Dickinson, San Jose, CA); anti-CCR6 (R&D systems, Minneapolis, MN); anti-blood dendritic cell antigen (BDCA)-2 and anti-BDCA-3 (Miltenyi Biotech, Auburn, CA). The following recombinant human cytokines were added to DC cultures: TNF-(10 ng/mL), IL-4 (500 U/mL) (both Peprotech Inc, Rocky Hill, NJ), GM-CSF (40 ng/mL) (Schering-Plough, Sydney, Australia) and IFN-2a (1000 IU/mL) (Roferon-A, Roche Products Pty Ltd, Sydney, Australia). PGE 2 (1µM final concentration) was purchased from Sigma Chemical Company (St Louis, MO). Soluble CD40L-trimer (CD40L)
(1 µg/mL final concentration) was a kind gift from Amgen Inc. (Seattle, WA). Relative expression was calculated using the Ct method and is expressed relative to a calibrator, in this case the GM-CSF/IL-4 DC control as previously described. 38 
Cell sources
Cytokine ELISAs
Cytokine secretion by stimulated DC or by allogeneic T cells was measured by cytokine Plates were read in a Thermomax microplate reader (BioMediq, Australia). (data not shown), consistent with a putative myeloid origin. Whereas CD1b/c + PBDC spontaneously up-regulated the expression of CD80, CD83 and CD86 following overnight culture in GM-CSF and IL-4-containing medium, 39 MoDC required maturation with specific combinations of stimuli. 39 As previously reported, FL-expanded CD1b/c + PBDC showed heterogeneous expression of MMR. 9 Additionally, discrete subpopulations within the CD1b/c + PBDC gate were also detected on the basis of CCR6 and BDCA-3 expression ( Figure 2B ). The percentage expression for MMR, CCR6 and BDCA-3 suggests that multiple subpopulations are likely to exist. Interestingly, CD1b/c + PBDC up-regulated surface expression of CD83 ( Figure 2C ) and HLA-DR (data not shown) more rapidly than MoDC, regardless of maturational stimulus. Furthermore, the mean fluorescence intensity of these markers was an order of magnitude greater for CD1b/c + PBDC compared to MoDC ( Figure   2C ).
T cell purification and Mixed Leukocyte Reaction
Results
Cell morphology and culture of MoDC and
Induction of cytokine secretion by highly purified CD1b/c + PBDC and MoDC
DC produce several types of cytokines following stimulation with pathogen or CD40L, such as IL-6, IL-10, IL-12p70. We compared cytokine secretion by CD1b/c + PBDC and MoDC in response to different classes of physiological stimuli. Figure 3A shows that MoDC secreted considerably more IL-6 compared to CD1b/c + PBDC, particularly in response to E.coli.
Similarly, MoDC secreted IL-10 in response to a range of stimuli, but produced the highest levels of IL-10 following stimulation with E.coli ( Figure 3B ). As previously reported, the addition of PGE 2 to CD40L or to E.coli decreased the amount of IL-10 produced by MoDC. In both studies, PBDC were initially cultured (thus matured) for at least 24h prior to stimulation with LPS or CD40L. 18, 40 We, therefore, evaluated whether in vitro maturation of CD1b/c + PBDC enhanced their responsiveness to IL-12p70-inducing stimuli such as CD40L, intact E.coli or the combination of IL-1 , IFN-, CD40L and E.coli. It was found that increased production of IL-12p70 was observed in response to the combination of GM-CSF, IL-1 , IFN-, CD40L and E.coli ( Figure 3D ) but not GM-CSF+CD40L nor GM-CSF+E.coli (data not shown). Figure 3D also shows that CD1b/c + PBDC required prolonged in vitro culture (24-48h) prior to stimulation in order to produce increased levels of IL-12p70 (~400pg/ml). Shorter times of in vitro-maturation (2-24h) prior to stimulation were not sufficient at enhancing IL-12p70 producing capacity. However, even under these optimized condit ions, IL -12p70 production by CD1b/c + PBDC was consistently lower than by MoDC.
Furthermore, Figure 3D Figure 4D shows that immature MoDC (GM-CSF+IL-4) constitutively produced low levels of bioactive IL-18 (~50pg/ml) and that secretion was increased upon stimulation with either CD40L or E.coli ( Figure 4D ). In contrast, CD1b/c + PBDC were poor producers of bioactive IL-18 irrespective of the type of stimulus encountered.
Analysis of migratory capacity of MoDC and CD1b/c + PBDC
Migration of antigen-loaded DC toward lymphoid organs is critical for the initiation of T cell immunity and requires the expression of the chemokine receptor, CCR7, to respond to the lymph node-directing chemokines, CCL19 (MIP-3 or ELC) or CCL21 (6Ckine or SLC Figure 3A -C) whilst at the same time inducing MoDC migratory function ( Figure 5C ). 38, 41 In contrast, PGE 2 was less critical at regulating these functions in CD1b/c + PBDC, which spontaneously migrated following maturation with all the classes of stimuli irrespective of the presence of PGE 2 ( Figure 5D ). 38, 41 We next examined whether the kinetics with which It has been proposed that MoDC depend upon exogenous PGE 2 as a consequence of IL-4 blocking endogenous PGE 2 production by immature MoDC. 42 Alternatively, CD1b/c + PBDCs, which are efficient migratory cells in the absence of PGE 2 -containing stimuli may secrete higher levels of PGE 2 in culture and thus not depend upon exogenous PGE 2 to acquire migratory function. To address these possibilities, we examined the levels of PGE 2 produced in culture SN by the two DC types. As shown in Figure 5E , both MoDC and CD1b/c + PBDC constitutively secreted comparable levels of PGE 2 in vitro and these levels were further increased following stimulation with E.coli. Although not conclusive, these data argue that the differences in migratory capacity between MoDC and CD1b/c + PBDC are not simply due to differences in the endogenous production of PGE 2 . 
Comparison of T cell stimulatory capacity of MoDC and
Presentation of synthetic peptide to CTL lines by MoDC and CD1b/c + PBDC
Finally, in order to assess antigen presentation to T cells, different populations of DC were used in a peptide-Ag presentation assay. In this assay, peptide-specific T cells were induced to produce IFN-following co-culture with peptide loaded DC. The peptides tested were HLA-A2-restricted peptides derived from the tumor-associated antigen, NY-ESO-1 (NY-ESO-1b [157] [158] [159] [160] [161] [162] [163] [164] [165] ) and the viral antigen, EBV BLMF-1 (BMLF-1 280-288 ). Short-term CTL lines were generated (2-5% peptide-specific as assessed by peptide tetramer analysis) following culture of PBMC for 7-10 days with the respective peptides and used as responders in the assays. As shown in Figure 9 , both CD1b/c + PBDC and autologous MoDC were equivalent, at the per cell level, to TAP-deficient T2 cells at presenting NY-ESO-1b 157-165 and EBV BMLF-1 [280] [281] [282] [283] [284] [285] [286] [287] [288] to peptide-specific CTL lines as assessed by intracellular IFN-staining. Importantly, both DC types could present peptides at between the 10 -7 and 10 -9 Molar range, indicating that both types of DC were efficient at presenting limiting concentrations of peptide to CTL lines.
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Discussion
The clinical application of DC requires a detailed understanding of their functional potential and how best to manipulate this for optimal vaccine delivery and immune induction. Both PBDC and MoDC are currently being evaluated in anti-cancer immunotherapy trials (see reviews 3, 4, 43 
38,41
Major differences in migratory capacity were observed between these two DC types. CD1b/c + PBDC migrated to chemokines shortly after culture (8-12h), this requiring only minimal in vitro manipulation (e.g. GM-CSF and IL-4), whereas MoDC required prolonged culture (24h) with PGE 2 -containing stimuli. PGE 2 appears to regulate MoDC migratory function via cAMP/protein kinase A activation. 38, 39 Interestingly, migratory-type MoDC (i.e. matured with PGE 2 -containing stimuli) exhibit a similar functional profile to CD1b/c + PBDC (i.e.
migratory, low IL-12p70 production and induction of IL-2 by T cells). PGE 2 has also been shown to abrogate IL-12p70 secretion by MoDC. 58, 59 Zelle-Rieser et al. also implicate IL-4-medated suppression of endogenous PGE 2 production by MoDC for the maturation-enhancing effects of exogenous PGE 2 . 42 However, we found that PGE 2 production by immature MoDC (GM-CSF+IL-4) was comparable to levels produced by CD1b/c + PBDC and that both DC populations increased PGE 2 production following stimulation. Thus, differences in the endogenous levels of PGE 2 between CD1b/c + PBDC and MoDC cannot completely explain their different migratory capacity. An alternative is that CD1b/c + PBDC are the product of a completely distinct stimulation history in vivo to MoDC. In particular, cyclic AMP (cAMP)
analogs, which can replace the ability of PGE 2 to induce MoDC migration, 38 are present in serum (e.g. vasoactive intestinal peptide 60 or sympathomimetics 61 ). It is possible that freshly isolated CD1b/c + PBDC have already been exposed to cAMP-inducing serum factors in situ and thus are pre-sensitized to migrate upon minimal in vitro stimulation. Work to address these specific questions is ongoing.
Analysis of the ability of each DC type to induce T cell function revealed that MoDC and
CD1b/c + PBDC were equivalent at inducing allo-reactive T cell proliferation and were as efficient as TAP-deficient T2 cells at presenting peptides to CTL lines. As reported, however, MoDC required prior maturation with specific stimuli to induce efficient T cell stimulation, 54, 62 whereas CD1b/c + PBDC (that spontaneously mature in vitro without additional stimuli) efficiently induce T cell stimulation. Major differences were also observed in the type and quantity of cytokines the DC populations induced T cells to secrete, this paralleling differences in IL-12p70 production by the DC types. Stimuli that maximally 
